Treatment with Dexamethasone and Monophosphoryl lipid a removes Disease-associated Transcriptional signatures in Monocyte-Derived Dendritic cells from rheumatoid arthritis Patients and confers Tolerogenic Features

Garcia-Gonzalez, PA; Schinnerling, K; Sepulveda-Gutierrez, A; Maggi, J; Hoyos, L; Morales, RA; Mehdi, AM; Nel, HJ; Soto, L; Pesce, B; Molina, MC; Cuchacovich, M; Larrondo, ML; Neira, O; Catalan, DF; et. al.

Keywords: tolerance, dendritic cells, rheumatoid arthritis, transcriptome, cell-based therapy

Más información

Título según WOS: Treatment with Dexamethasone and Monophosphoryl lipid a removes Disease-associated Transcriptional signatures in Monocyte-Derived Dendritic cells from rheumatoid arthritis Patients and confers Tolerogenic Features
Título según SCOPUS: Treatment with dexamethasone and monophosphoryl lipid a removes disease-associated transcriptional signatures in monocyte-derived dendritic cells from rheumatoid arthritis patients and confers tolerogenic features
Título de la Revista: FRONTIERS IN IMMUNOLOGY
Volumen: 7
Número: OCT
Editorial: Frontiers Media S. A.
Fecha de publicación: 2016
Idioma: English
DOI:

10.3389/fimmu.2016.00458

Notas: ISI, SCOPUS